Anatara Lifesciences Ltd (ASX:ANR) CEO Steve Lydeamore is interviewed by ABN Newswire, and talks about the human trials as well as the product pipeline for next year.
As Anatara moves forward, the Board is confident in the knowledge that a substantial market opportunity for Detach(R) remains, with more pressure than ever on producers to reduce their antibiotic use and find suitable alternatives which minimise illnesses, such as scour, on farms.
The Food management team at T12, are proud to announce the release of our new and nutritious 'Black Label' Hemp Seed Oil and Hemp Seed mixes product range for the discerning Australian and Asian consumer.
Cann Global Ltd (ASX:CGB) is pleased to advise that the Company has secured further institutional support from New York based L1 Capital Global Opportunities Master Fund ("L1" or "Investor"). The Company has agreed to issue 2,600,000 secured convertible notes (Notes) to raise $2.22M after costs.
Cann Global Limited (ASX:CGB) presents its Quarterly report for the three months ended 30 September 2019.
Regeneus Ltd (ASX:RGS) (Regeneus or the Company), a clinical-stage regenerative medicine company, today released its quarterly cashflow report for the period ending 30 September 2019 (Q1 FY20).
Bluechiip Ltd (ASX:BCT) is offering Eligible Shareholders the opportunity to participate in the Bluechiip Share Purchase Plan (SPP).
